Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy-related toxicity

Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy-related toxicity

US Patent 10899831 · Granted Jan 26, 2021

Estimated economic value: $34,388,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EphA3 directed CAR-T cells for treatment of tumors2024
EphA3 directed CAR-T cells for treatment of tumors2024
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF2021
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist2020
Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist2020
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2020